Start Date:6 NOVEMBER, 2025
Start Time:4:00 PM CET | 9:00 AM CST
Duration:45 minutes
Abstract:
As the demand for science-backed, non-hormonal solutions in menopause care continues to grow, consumer health companies face increasing pressure to bring clinically credible products to market. This webinar will explore how a precision three-strain probiotic—developed by AB-BIOTICS and Kaneka Probiotics—addresses this need with targeted action on the estrobolome, a key regulator of estrogen metabolism. The program will focus on two key areas: the estrobolome as a novel target in menopause care, with practical guidance on probiotic use, and the latest clinical evidence supporting innovative probiotic formulations. Designed for professionals in pharmaceutical and consumer health companies, this 45-minute session blends scientific rigor with real-world application. The agenda is structured to provide a comprehensive overview, from foundational science to clinical evidence and commercial opportunities, and will conclude with a live Q&A.
General Enquiries:
marketing@cnsmedia.com
Speakers
 Franco Vicariotto, MD Obstetrician-Gynecologist Dr. Franco Vicariotto is a women’s microbiota expert with over 30 years of clinical experience. He is a consultant at Humanitas San Pio X Hospital (Milan) and co-founder of SIFIOG, the Italian Society of Supplements in Obstetrics and Gynecology. He serves on the boards of several scientific societies, including SIM, ISVVD, and the International Probiotics Association (IPA). Dr. Vicariotto has published extensively on probiotics in gynecology, frequently presents at international conferences, and is the author of The Female Microbiome: Biotic Solutions in Gynecology.  Marta Perez, PhD Senior Scientific Project Manager AB-BIOTICS Dr. Marta Perez holds a PhD in Molecular Microbiology with a specialization in human microbiota and probiotics. She has built her career at leading international research institutions in Spain, the Netherlands, and Ireland, gaining extensive expertise in microbiology and molecular biology. Her recent work focuses on developing innovative biosolutions to enhance women’s health, actively participating in the discovery, development, and clinical validation of bacteria-based therapies.  Jolanda van Hal Senior Journalist CNS Media B.V. Jolanda van Hal is a senior journalist for the NutritionInsight platform. She has a background in natural ingredients for health products and cosmetics, supporting exporters to enter the EU with market research, training, coaching and market access.
|
|
First Name
|
|
Last Name
|
|
Email Address
|
|
Country
|
|
Company
|
|
Job Function
|
|
|
By registering for this free webinar, you agree to receive communications from CNS Media and this event's sponsor.
To learn more about how we protect your details, please read our Privacy Statement. |
|
|